MedTrace Logo

Memantine in Patients With Chronic Glaucoma

NCT00168350 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1179

Last updated 2010-11-04

No results posted yet for this study

Summary

Randomized double-masked clinical trial of memantine in patients with glaucoma

Conditions

  • Open-Angle Glaucoma

Interventions

DRUG

memantine

Sponsors & Collaborators

  • Allergan

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
82 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Primary Completion
2006-09-30
Completion
2006-09-30

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00168350 on ClinicalTrials.gov